The new treatments in migraine: First year clinical experience

Headache Quarterly

Volumn 11, Issue 1, 2000, Pages 33-36

  Freitag, Frederick G ^a,b,c   Diamond, Seymour ^b,d   Diamond, Merle L ^a   Urban, George J ^a,b   Pepper, Betsy J ^a  

^a DIAMOND HEADACHE CLINIC   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

^d Diamond Inpatient Headache Unit   (United States)

Author keywords

Dihydroergotamine; Migraine treatment; Naratriptan; Rizatriptan; Triptans; Zolmitriptan

Indexed keywords

DIHYDROERGOTAMINE; DIHYDROERGOTAMINE MESILATE; NARATRIPTAN; RIZATRIPTAN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; ZOLMITRIPTAN;

ADOLESCENT; ADULT; AFFECTIVE NEUROSIS; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIGRAINE; NAUSEA; NOSE CONGESTION; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SEROTONIN SYNDROME; SORE THROAT; THORAX PAIN; TREATMENT OUTCOME; VERTIGO; VOMITING;

EID: 0034113444     PISSN: 10597565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Gallagher RM. Acute treatment of migraine with dihydroer-gotamine nasal spray. Arch Neurol 1996; 53:1285-1291.
2. Mathew NT, Asgharnejad M, Peykamian M, Laurenza A, on behalf of the Naratriptan 52WA3003 Study Group. Naratriptan is effective and well-tolerated in the acute treatment of migraine. Results of a double-blind placebo-controlled crossover study. Neurology 1997; 49:1485-1490.
3. Kramer MS, Matzura-Wolfe D, Polis A, Getson A, Amaraneni PG, Reines SA, and the Rizatriptan Multiple Attack Study Group. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Neurology 1998; 51:773-781.
4. Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM, on behalf of The 042 Clinical Trial Study Group. Clinical efficacy and tolerability of 2.5mg zolmitriptan for the acute treatment of migraine. Neurology 1997; 49: 1219-1225.
5. Mathew NT, Asgharnejad M, Peykamian M, Laurenza A. Naratiptan is effective and well-tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. Neurology 1997; 49:1485-1490.
6. Kramer MS, Matzura-Wolfe D, Polis A, Getson A, Amaraneni PG, Solbach MP, et al. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Neurology 1998; 51:773-781.
7. Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM. Clinical efficacy and tolerability of 2.5mg zolmitriptan for the acute treatment of migraine. Neurology 1997; 49:1219-1225.